- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Refractory or Relapsed Non-Hodgkin's Lymphoma in United States
Total 3009 results
-
Royal Marsden NHS Foundation TrustMerck Sharp & Dohme LLC; Mundipharma-EDO GmbHWithdrawnRelapsed or Refractory Diffuse Large B-cell LymphomaUnited Kingdom
-
Children's Hospital Los AngelesCompletedHodgkins Lymphoma | Non-hodgkins LymphomaUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedNon-Hodgkin's LymphomaUnited States
-
Academic and Community Cancer Research UnitedMayo ClinicCompleted
-
M.D. Anderson Cancer CenterNovartisCompletedLymphoma | Non-Hodgkin's LymphomaUnited States
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)Terminated
-
Acrotech Biopharma Inc.CompletedB-cell Lymphoma | Hodgkin's Lymphoma | Relapsed or Refractory Lymphoproliferative Malignancies | Peripheral T-cell Lymphoma | Waldenstrom's MacroglobulinemiaUnited States
-
Memorial Sloan Kettering Cancer CenterOhio State University; Pharmacyclics LLC.; Janssen Biotech, Inc.CompletedT-cell Lymphoma | Relapsed and Refractory T-cell LymphomaUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Genentech, Inc.; Otsuka America PharmaceuticalCompletedNon-Hodgkin's Lymphoma | CNS LymphomaUnited States
-
Gilead SciencesTerminatedFollicular Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Non-hodgkin's Lymphoma | Small Lymphocytic LymphomaUnited States
-
St. Jude Children's Research HospitalTerminatedYoga to Alleviate Fatigue, Anxiety and Pain in Adolescents During Treatment for Lymphoma or LeukemiaLeukemia | Hodgkin Lymphoma | Lymphoma, Non-Hodgkin'sUnited States
-
TG Therapeutics, Inc.CompletedB-cell Lymphoma | Marginal Zone Lymphoma | Primary Central Nervous System Lymphoma | Waldenstrom's Macroglobulinemia | Non-Hodgkins Lymphoma | Chronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL)United States
-
Dana-Farber Cancer InstituteLeadiant Biosciences, Inc.TerminatedT-Cell Lymphoma | Relapsed T-Cell Lymphoma | Refractory T-Cell LymphomaUnited States
-
Weill Medical College of Cornell UniversityCompleted
-
Dana-Farber Cancer InstituteCompletedNon-Hodgkin's LymphomaUnited States
-
Seagen Inc.TerminatedFollicular B-cell Non-Hodgkin's Lymphoma | Diffuse Large B-cell Lymphoma RefractoryUnited States, Italy, Spain, United Kingdom, Czechia, Poland, France
-
Kite, A Gilead CompanyPfizerTerminatedRelapsed/Refractory Large B-cell LymphomaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); The Wayne D. Kuni and Joan E. Kuni FoundationCompletedDiffuse Large B-Cell Lymphoma | Acute Myeloid Leukemia | Refractory Hodgkin Lymphoma | Previously Treated Myelodysplastic Syndrome | Recurrent Mantle Cell Lymphoma | Waldenstrom Macroglobulinemia | Acute Lymphoblastic Leukemia | Refractory Plasma Cell Myeloma | Recurrent Small Lymphocytic Lymphoma | Refractory... and other conditionsUnited States
-
Novartis PharmaceuticalsXOMA (US) LLCCompletedHodgkin's Lymphoma | Non-Hodgkin's LymphomaUnited States, Belgium, Canada, Italy, France, Hong Kong, Australia, United Kingdom, Singapore, Korea, Republic of, Germany
-
S*BIOCompletedLymphoma, Malignant | Hodgkin's Lymphoma | B Cell LymphomaUnited States
-
Benjamin TomlinsonRecruitingAcute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia | Non Hodgkin LymphomaUnited States
-
Burzynski Research InstituteCompletedLow-Grade LymphomaUnited States
-
Weill Medical College of Cornell UniversityBayerCompletedT-Cell Lymphoma | Lymphoma, Non-Hodgkin'sUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLymphoma | LeukemiaUnited States, Canada
-
University of RochesterMillennium Pharmaceuticals, Inc.; CephalonCompletedNon-Hodgkin's LymphomaUnited States
-
AbbVieGenentech, Inc.WithdrawnNon-Hodgkin's LymphomaUnited States
-
University of Michigan Rogel Cancer CenterCompletedLymphoma, Non-Hodgkin'sUnited States
-
University of Michigan Rogel Cancer CenterTerminatedLymphoma, Non-Hodgkin'sUnited States
-
AstraZenecaCLL ConsortiumCompletedB Cell Lymphomas | 11q-deleted Relapsed/Refractory Chronic Lymphocytic Leukaemia (CLL), | Prolymphocytic Leukaemia (PLL)United States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)TerminatedAcute Lymphoblastic Leukemia | Mantle Cell Lymphoma | Non-Hodgkin Lymphoma | Myelodysplastic Syndrome | Plasma Cell Myeloma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Minimal Residual Disease | Therapy-Related Acute Myeloid Leukemia | Therapy-Related Myelodysplastic... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Marginal Zone Lymphoma | Waldenstrom Macroglobulinemia | Recurrent Adult Hodgkin Lymphoma | Recurrent Non-Hodgkin Lymphoma | Recurrent T-Cell Non-Hodgkin Lymphoma | Recurrent Follicular Lymphoma | Recurrent Lymphoplasmacytic Lymphoma | AIDS-Related Hodgkin LymphomaUnited States
-
Nordic NanovectorICON Clinical ResearchActive, not recruitingFollicular Lymphoma | Non-Hodgkin LymphomaUnited States, Korea, Republic of, Australia, Austria, Belgium, Canada, Croatia, Czechia, Denmark, Finland, France, Hungary, Ireland, Israel, Italy, Netherlands, Norway, Poland, Singapore, Spain, Sweden, Switzerland, Turkey, United Kingdom
-
H. Lee Moffitt Cancer Center and Research InstituteNovartis PharmaceuticalsTerminatedNon-Hodgkin's LymphomaUnited States
-
University of NebraskaBristol-Myers SquibbCompleted
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Unknown
-
University of Alabama at BirminghamNational Cancer Institute (NCI)Completed
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's Hospital; University of Rochester and other collaboratorsCompletedNon-Hodgkin's LymphomaUnited States
-
Corixa CorporationGlaxoSmithKlineUnknownNon-Hodgkin's LymphomaUnited States
-
OncoMed Pharmaceuticals, Inc.CompletedRelapsed or Refractory Lymphoid MalignanciesUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnRecurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Recurrent T-Cell Non-Hodgkin Lymphoma | Recurrent High Grade B-Cell Lymphoma | Recurrent Aggressive Non-Hodgkin Lymphoma | Recurrent Burkitt Lymphoma | Recurrent Transformed B-Cell Non-Hodgkin LymphomaUnited States
-
Georgetown UniversityCelgene Corporation; CephalonCompletedNon-Hodgkin's Lymphoma | Chronic Lymphocytic LeukemiaUnited States
-
Dana-Farber Cancer InstituteSanofi; Genzyme, a Sanofi CompanyTerminatedNon Hodgkin Lymphoma | Diffuse Large B Cell Lymphoma | High-grade B-cell LymphomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingFollicular Lymphoma | Non-Hodgkin's Lymphoma | NHLUnited States
-
Fred Hutchinson Cancer CenterADC TherapeuticsWithdrawnRecurrent Diffuse Large B-Cell Lymphoma | Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | Recurrent High... and other conditionsUnited States
-
Gilead SciencesCompletedNon-Hodgkin's LymphomaUnited States
-
Northwestern UniversityRobert H. Lurie Cancer CenterCompletedNon-Hodgkin's LymphomaUnited States
-
University of NebraskaGlaxoSmithKline; Celgene CorporationCompletedNon-Hodgkin's LymphomaUnited States
-
Corixa CorporationGlaxoSmithKlineUnknown
-
ADC Therapeutics S.A.TerminatedRelapsed Follicular Lymphoma | Refractory Follicular LymphomaUnited States, Belgium, Hungary, Israel, Spain, Switzerland, Poland, France, United Kingdom, Italy